AN UNBIASED VIEW OF MODAFINIL NORGE

No unique dose adjustment advised when tofacitinib coadministered with strong CYP2C19 inhibitors; decrease tofacitinib dose if coadministered with both of those reasonable CYP3A4 and strong CYP2C19 inhibitors .Minimal (one)modafinil will boost the stage or outcome of lansoprazole by influencing hepatic enzyme CYP2C19 metabolism. Minor/Significance